Canada markets open in 7 hours 48 minutes

Amylyx Pharmaceuticals, Inc. (AMLX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.9900-0.0400 (-1.97%)
At close: 04:00PM EDT
2.0200 +0.03 (+1.51%)
After hours: 07:56PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 134.99M
Enterprise Value -232.13M
Trailing P/E 2.84
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.36
Price/Book (mrq)0.31
Enterprise Value/Revenue -0.61
Enterprise Value/EBITDA -5.82

Trading Information

Stock Price History

Beta (5Y Monthly) -0.93
52-Week Change 3-93.26%
S&P500 52-Week Change 324.49%
52 Week High 330.5000
52 Week Low 31.7000
50-Day Moving Average 35.7538
200-Day Moving Average 314.4345

Share Statistics

Avg Vol (3 month) 33.54M
Avg Vol (10 day) 32.16M
Shares Outstanding 568.01M
Implied Shares Outstanding 669.32M
Float 851.35M
% Held by Insiders 115.12%
% Held by Institutions 1103.95%
Shares Short (Apr 15, 2024) 46.51M
Short Ratio (Apr 15, 2024) 42.43
Short % of Float (Apr 15, 2024) 410.54%
Short % of Shares Outstanding (Apr 15, 2024) 49.58%
Shares Short (prior month Mar 15, 2024) 45.09M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 12.94%
Operating Margin (ttm)1.78%

Management Effectiveness

Return on Assets (ttm)5.34%
Return on Equity (ttm)12.73%

Income Statement

Revenue (ttm)380.79M
Revenue Per Share (ttm)5.66
Quarterly Revenue Growth (yoy)395.50%
Gross Profit (ttm)N/A
EBITDA 39.89M
Net Income Avi to Common (ttm)49.27M
Diluted EPS (ttm)0.7000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)371.36M
Total Cash Per Share (mrq)5.48
Total Debt (mrq)4.24M
Total Debt/Equity (mrq)0.98%
Current Ratio (mrq)5.66
Book Value Per Share (mrq)6.52

Cash Flow Statement

Operating Cash Flow (ttm)11.92M
Levered Free Cash Flow (ttm)38.36M